MHRA reforms will speed up path for rare therapies
By Liz Wells 03 November 2025
The rulebook for rare disease therapies will be overhauled to make it quicker and easier to get these therapies tested, manufactured and approved in the UK, the MHRA has announced in a new paper.
DoLS Coordinator
Grade 6, £26,825 to £28,142 per annum pro-rata (actual salary £15,950 to £16,733.08)
Newport, Isle of WightGrade 6, £26,825 to £28,142 per annum pro-rata (actual salary £15,950 to £16,733.08)
Head of Service – Social Care
£60k pa plus International Supplement
Saint Helena, Ascension and Tristan da Cunha (SH)£60k pa plus International Supplement
Lead Child Protection Practitioner
£54,143 - £56,293 per annum
Gloucestershire £54,143 - £56,293 per annum
Most Read News
DoLS Coordinator
Grade 6, £26,825 to £28,142 per annum pro-rata (actual salary £15,950 to £16,733.08)
Newport, Isle of WightGrade 6, £26,825 to £28,142 per annum pro-rata (actual salary £15,950 to £16,733.08)
Head of Service – Social Care
£60k pa plus International Supplement
Saint Helena, Ascension and Tristan da Cunha (SH)£60k pa plus International Supplement
Lead Child Protection Practitioner
£54,143 - £56,293 per annum
Gloucestershire £54,143 - £56,293 per annum
Most Read News
©2026 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
